Clinical Trials Browser

Phase 2 × Adenocarcinoma of Lung × Drug Therapy × Clear all

NCT02621333 2021-05-12

Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma

Phase 2 Terminated

Adenocarcinoma of Lung

NCT03544814 2019-10-15

EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression

Phase 2 Completed

Adenocarcinoma of Lung